PUNE, India, September 12, 2016 /PRNewswire/ --
The global defibrillators market is forecast to reach $14.21 billion by 2021 from $10.01 billion in 2016 at a CAGR of 7.3% driven by the development of technologically advanced defibrillators, rapid growth in the aging population with high risk of target diseases, rising incidences of cardiovascular diseases across the globe and growing focus of key market players toward public access defibrillation.
Complete report on global defibrillators market spread across 161 pages, profiling 10 companies and supported with 84 tables and 36 figures is now available at http://www.reportsnreports.com/reports/344031-defibrillators-market-by-product-implantable-cardioverter-defibrillator-single-dual-chamber-crt-d-s-icd-and-external-monitor-defibrillator-aed-wearable-by-end-user-hospital-pre-hospital-public-access-home-global-forecast-to-2019.html .
Geographically, the report covers four major regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the global defibrillators market in 2016, followed by Europe. The Asia-Pacific defibrillators market is projected to witness the highest growth rate during the forecast period from 2016 to 2021 due to a number of factors, including improving healthcare infrastructure, favorable government initiatives, and growing focus of market players on the Asia-Pacific defibrillators market.
As of 2015, the global defibrillators market was dominated by Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), Koninklijke Philips N.V. (Netherlands), and ZOLL Medical Corporation (U.S.), which together held a share of ~90% of the overall defibrillators market. The defibrillators market is broadly segmented into products and end users. By products, the defibrillators market is segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. The external defibrillators segment is categorized into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs). The AEDs segment is further divided into semi-automated external defibrillators and fully automated external defibrillators. The ICDs segment is expected to account for the largest share of the global defibrillators market in 2016. However, automated external defibrillators segment is projected to grow at the highest CAGR during the forecast period due to a number of new product launches, increasing prevalence of cardiovascular diseases, rising government initiatives, and growing number of public access defibrillation programs.
The major players involved in the global defibrillators market are Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), and Nihon Kohden Corporation (Japan). Order a copy of "Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospital, Prehospital, Public Access, Home) - Global Forecasts to 2021" research report at http://www.reportsnreports.com/purchase.aspx?name=344031 .
The target audiences of the defibrillators market report are Defibrillator manufacturers, vendors, and distributors, Defibrillator services companies, Research institutes and government organizations, Venture capitalists and other government funding organizations, Research and consulting firms, Healthcare institutions (hospitals and medical schools), Medical device suppliers and distributors and Group purchasing organizations (GPOs).
On a related note, another research on Cardiac Monitoring & Cardiac Rhythm Management Market Global Forecast to 2020 says, the global cardiac monitoring and cardiac rhythm management (CRM) devices market is poised to reach $26,646.5 Million by 2020 from $21,137.7 Million in 2015, at a CAGR of 4.7% from 2015 to 2020 driven by increasing incidences of cardiovascular diseases, technological advancement such as mobile cardiac telemetry, and emergence of private institutional nursing and home care. However, dearth of skilled healthcare professionals with expertise in electrocardiography (ECG) and cardiac monitoring, and pressure to contain healthcare costs hampering complete adoption of advanced technologies are the major factors restraining the growth of the market. Companies like Biotronik Inc. (Germany), Boston Scientific Inc. (U.S.), Cardiac Science Co. (U.S.), GE Healthcare (U.K.), Medtronic Inc. (U.S.), Mortara Instrument Inc. (U.S.), Philips Healthcare (The Netherlands), Schiller Ag (Switzerland), Sorin S.P.A. (Italy), St. Jude Medical Inc. (U.S.) have been profile in this 250 pages research report available at http://www.reportsnreports.com/reports/218817-cardiac-monitoring-cardiac-rhythm-management-crm-market-ecg-implantable-loop-recorder-holter-implantable-cardioverter-defibrillator-icd-automated-external-defibrillator-aed-pacemaker-crt-d-crt-p-global-forecasts-to-2017.html .
Explore more reports on Medical Devices market at http://www.reportsnreports.com/market-research/medical-devices/ .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
2nd Floor, Metropole,
Next to Inox Theatre, Bund Garden Road,
Pune - 411001.
Connect With Us on:
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts